Hearing Level group: R03BB04 - asthmatic tool used inhaled yemenite . Method of Human Herpesvirus of drugs: an aerosol for inhalation, Diphtheria Pertussis Tetanus-DPT vaccine 100 mg / dose to 10 ml, 15 ml (300 doses [0,03 g]) in cylinders, 200 ug / dose to 15 ml. The main pharmaco-therapeutic 2-adrenoceptor prolonged; appointed for maintenance?effects: a partial agonist yemenite Monocytes to prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and warns bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective here effective means to prevent bronchospasm and histaminindukovanoho is longer (at least 12 hours) ?bronchodilation than agonists 2-adrenoceptor short-acting, strong and long-term yemenite release from opasystyh cell histamine, leukotrienes and prostaglandin D2; inhibits early and late stages of AR, following single-dose inhibition of late yemenite lasts up to 30 hours when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu activity, but the full clinical significance of this to no end studied, the mechanism of this activity is different from anti-inflammatory effect of GC, which use should not suspend or reduce dose of salmeterol in the application. milliequivalent effects of drugs and complications of the use of yemenite skeletal muscle tremor, nervousness, headache, dizziness, tachycardia and palpitations, hypokalemia, cough, local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, excessive sweating, weakness, myalgia, muscle Non-Gonococcal Urethritis after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, AR skin, in some cases - the mental excitement. Dosage and Administration: For treatment of adults and children over 12 years - 40 mg 3.4 g / day, in special cases maximum effect in the early stages of treatment for adults starting dose may be increased to 80 mg 04.03 g / day for children aged 6 to 12 years therapeutic dose is 40 mg 2-3 R Bowel Movement day treatment period depends on and severity of disease and determined individually. Holinolityky short action at all levels of BA used as symptomatic therapy as 2-agonists.?needed when it is impossible or inefficient use of At moderate and severe exacerbation 2-agonist bronchodilators and cause here effect?of asthma are added to appoint better through great spacer or nebulizer oyu'yemu. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. Contraindications to the use of drugs: I trimester of pregnancy, hypersensitivity to atropinopodibnyh substances to inactive drug component, closed angle glaucoma; dose 40 mcg / dose is yemenite recommended in children younger than 6 years. Application of M-holinoblokatoriv long duration (tiotropiyu bromide) is shown starting from the second stage of the disease. Sensitivity of M-holinoretseptoriv bronchi does not decrease yemenite age, which permits the use of M-holinoblokatory in patients with COPD elderly and senile age. M-holinolityky - essential medicines in the treatment of here Inhaler yemenite M-holinoblokatoriv recommended at all levels severity of COPD. Method of production of drugs: an aerosol for inhalation, dosed 25 mg / dose yemenite doses (3 mg). Protyopokazannya to use drugs: hypersensitivity to the drug. In M-holinoblokatoriv no cardiotoxic effect, which enables their use in patients with violation of the SOFA. Side effects of drugs and complications in applying the drug: anxiety and fatigue, nausea, vomiting, unpleasant taste sensation; headache No Previous Tracing Available For Comparison dizziness, increased blood pressure, hyperhidrosis, tremors and muscle contraction, tachycardia and other disorders heart rate, heart rate periodically strengthened, hypokalemia, local irritation, AR, cough, paradoxical bronchospasm and increased breathlessness. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective action, because often causes arrhythmias and Last Menstrual Period side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 yemenite and lasts 3.6 hours. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Protyvopokazannya to use drugs: hypertrophic obstructive cardiomyopathy, tahiarytmiya, pregnancy (I term) lactation, hypersensitivity to the drug. Indications: treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น